Literature DB >> 15769611

Involvement of adenomatous polyposis coli in colorectal tumorigenesis.

Aruna S Jaiswal1, Ramesh Balusu, Satya Narayan.   

Abstract

Colorectal cancer arises after a series of mutations in various tumor suppressor and proto-oncogenes, each of which is accompanied by specific alterations and pathological conditions. Recent advances have contributed a great deal of understanding of the molecular basis of events that lead to colorectal tumorigenesis. Mutation in the adenomatous polyposis coli (APC) gene is considered to be one of the earliest events in the colon cancer development. The familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC) are the most commonly inherited colorectal cancers. FAP and HNPCC develop due to mutations in APC and DNA mismatch repair (MMR) genes, respectively. APC is known to regulate the levels of beta-catenin, an important mediator of cell-cell adhesion and transcriptional regulator. Mutations in APC gene are also linked with chromosomal instability in colon cancer cells. The role of APC is also implicated in cell migration, cell-cell adhesion, cell cycle control, and apoptosis. This article summarizes the structure-function studies and the role of APC mutations in colon cancer development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15769611     DOI: 10.2741/1605

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  8 in total

1.  Mechanism of adenomatous polyposis coli (APC)-mediated blockage of long-patch base excision repair.

Authors:  Aruna S Jaiswal; Ramesh Balusu; Melissa L Armas; Chanakya N Kundu; Satya Narayan
Journal:  Biochemistry       Date:  2006-11-30       Impact factor: 3.162

2.  Assembly of the base excision repair complex on abasic DNA and role of adenomatous polyposis coli on its functional activity.

Authors:  Aruna S Jaiswal; Satya Narayan
Journal:  Biochemistry       Date:  2011-02-04       Impact factor: 3.162

3.  Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.

Authors:  Yutaka Suehiro; Chi Wai Wong; Lucian R Chirieac; Yutaka Kondo; Lanlan Shen; C Renee Webb; Yee Wai Chan; Annie S Y Chan; Tsun Leung Chan; Tsung-Teh Wu; Asif Rashid; Yuichiro Hamanaka; Yuji Hinoda; Rhonda L Shannon; Xuemei Wang; Jeffrey Morris; Jean-Pierre J Issa; Siu Tsan Yuen; Suet Yi Leung; Stanley R Hamilton
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

4.  Genetic pathways to colorectal cancer.

Authors:  Isabel A Lea; Marcus A Jackson; June K Dunnick
Journal:  Mutat Res       Date:  2009-07-01       Impact factor: 2.433

5.  CD4+ lymphocytes modulate prostate cancer progression in mice.

Authors:  Theofilos Poutahidis; Varada P Rao; Werner Olipitz; Christie L Taylor; Erin A Jackson; Tatiana Levkovich; Chung Wei Lee; James G Fox; Zhongming Ge; Susan E Erdman
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

6.  Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.

Authors:  L W M Loo; C Ton; Y-W Wang; D I Grove; H Bouzek; N Vartanian; M-G Lin; X Yuan; T L Lawton; J R Daling; K E Malone; C I Li; L Hsu; P L Porter
Journal:  Genes Chromosomes Cancer       Date:  2008-12       Impact factor: 5.006

Review 7.  Epigenetic gene silencing in the Wnt pathway in breast cancer.

Authors:  George J Klarmann; Amy Decker; William L Farrar
Journal:  Epigenetics       Date:  2008-03-12       Impact factor: 4.528

8.  The nucleoside analog clitocine is a potent and efficacious readthrough agent.

Authors:  Westley J Friesen; Christopher R Trotta; Yuki Tomizawa; Jin Zhuo; Briana Johnson; Jairo Sierra; Bijoyita Roy; Marla Weetall; Jean Hedrick; Josephine Sheedy; James Takasugi; Young-Choon Moon; Suresh Babu; Ramil Baiazitov; John D Leszyk; Thomas W Davis; Joseph M Colacino; Stuart W Peltz; Ellen M Welch
Journal:  RNA       Date:  2017-01-17       Impact factor: 4.942

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.